IM Cannabis (IMCC) Cash & Current Investments (2019 - 2026)
IM Cannabis' (IMCC) quarterly Cash & Current Investments came in at $732122.5 in Q1 2026, down 24.37% year-on-year from $968017.0 in Q1 2025, and down 77.33% quarter-over-quarter from $3.2 million in Q4 2025.
IM Cannabis (IMCC) Cash & Current Investments (2019 - 2026) Analysis & Trends
IM Cannabis' Cash & Current Investments history runs 8 years deep, the most recent figure standing at $732122.5 for Q1 2026.
- On a quarterly basis, Cash & Current Investments fell 24.37% year-over-year to $732122.5 in Q1 2026; TTM through Mar 2026 was $732122.5, a 24.37% decrease from a year earlier, with the FY2025 full-year figure at $3.2 million, up 77.26% from the prior year.
- Cash & Current Investments eased to $732122.5 in Q1 2026 per IMCC's latest filing, from $3.2 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $12.1 million in Q1 2022 and bottomed at $573039.7 in Q2 2025.
- The 5-year median for Cash & Current Investments is $2.1 million (2023), against an average of $3.0 million.
- Biggest YoY gain for Cash & Current Investments was 90.14% in 2022; the steepest drop was 80.71% in 2022.
- Year by year, Cash & Current Investments stood at $3.6 million in 2022, then dropped by 15.91% to $3.0 million in 2023, then slumped by 40.69% to $1.8 million in 2024, then jumped by 80.87% to $3.2 million in 2025, then slumped by 77.33% to $732122.5 in 2026.
- Per Business Quant, the three latest IMCC Cash & Current Investments figures stand at $732122.5 (Q1 2026), $3.2 million (Q4 2025), and $1.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | 1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.63 Bn | 30.69 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 4.06 Bn |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn | 2.15 Bn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 1.32 Bn |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | 428.00 Mn |
| 10 | IM Cannabis | 525,798.39 | -206,324.13 | 1.03 Mn | 732,122.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 732,122.51 |
| Dec 31, 2025 | 3.23 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 573,039.72 |
| Mar 31, 2025 | 968,016.99 |
| Dec 31, 2024 | 1.79 Mn |
| Sep 30, 2024 | 3.52 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 3.01 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 2.09 Mn |
| Mar 31, 2023 | 2.65 Mn |
| Dec 31, 2022 | 3.58 Mn |
| Sep 30, 2022 | 3.12 Mn |
| Jun 30, 2022 | 6.97 Mn |
| Mar 31, 2022 | 12.13 Mn |
| Dec 31, 2021 | 11.04 Mn |
| Sep 30, 2021 | 16.19 Mn |
| Jun 30, 2021 | 29.96 Mn |